Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by CUR2004on Jan 09, 2013 8:38pm
237 Views
Post# 20818108

Royalty tracking

Royalty tracking

 

   Diagnocure  Hologic / Gen-Probe
   CUR - Royalty  PCA3 Royalty G-P Sales Cumul. Sales
         
Q 1 - 2008                40 787  $ 8%         509 838  $         509 838  $
Q 2 - 2008                46 591  $ 8%         582 388  $     1 092 225  $
Q 3 - 2008                64 239  $ 8%         802 988  $     1 895 213  $
Q 4 - 2008              110 770  $ 8%     1 384 625  $     3 279 838  $
Q 1 - 2009              132 311  $ 8%     1 653 888  $     4 933 725  $
Q 2 - 2009              145 107  $ 8%     1 813 838  $     6 747 563  $
Q 3 - 2009              113 687  $ 8%     1 421 088  $     8 168 650  $
Q 4 - 2009                81 033  $ 8%     1 012 913  $     9 181 563  $
Q 1 - 2010              128 345  $ 8%     1 604 313  $   10 785 875  $
Q 2 - 2010              153 190  $ 8%     1 914 875  $   12 700 750  $
Q 3 - 2010              158 076  $ 8%     1 975 950  $   14 676 700  $
Q 4 - 2010              138 882  $ 8%     1 736 025  $   16 412 725  $
Q 1 - 2011              160 725  $ 8%     2 009 063  $   18 421 788  $
Q 2 - 2011              172 718  $ 8%     2 158 975  $   20 580 763  $
Q 3 - 2011              162 534  $ 8%     2 031 675  $   22 612 438  $
Q 4 - 2011              126 240  $ 8%     1 578 000  $   24 190 438  $
Q 1 - 2012              145 012  $ 8%     1 812 650  $   26 003 088  $
Q 2 - 2012              168 663  $ 8%     2 108 288  $   28 111 375  $
Q 3 - 2012              142 102  $ 8%     1 776 275  $   29 887 650  $
Q 4 - 2012               8%     

 

<< Previous
Bullboard Posts
Next >>